Using an estrogen hormone like estradiol may help reduce inflammation and nerve damage in progressive forms of MS, a study in ...

COVID-19 can trigger serious brain and nerve problems, including stroke, seizures, and memory loss, even weeks after recovery ...

A recent study reveals increased incidence of CNS demyelination in patients treated with biologic agents for rheumatologic ...

Lucid-MS is a first-in-class therapy targeting demyelination in MS. The submission supports Quantum's global strategy to speed clinical advancement and patient access through strategic regulatory ...

Demyelination-linked disorders often show sex differences, and in the study, published Nov. 28 in Science, the researchers looked for underlying mechanisms of demyelination that might help explain ...

Nilotinib is a second-generation tyrosine kinase inhibitor targeting the BCR-ABL translocation in chronic myeloid leukaemia (CML). We present two cases of central nervous (CNS) demyelination whilst on ...

We validated our minipig model of demyelinating brain diseases by employing human diagnostic tools and comparing it with biopsy data from patients with cerebral demyelination.

They found that the antibody treatment attenuated neuroinflammation and the entry of CD4+ and CD8+ T cells into the brain, and it reduced demyelination. A clever genetic trick — a Thy1.1 reporter ...

Demyelination is the progressive damage to the myelin sheath, a protective covering that surrounds a nerve's axon. Due to its high sensitivity to microscopic tissue changes, diffusion tensor imaging ...